NCT04226352View on ClinicalTrials.gov

Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 15, 2020

Primary Completion Date

December 7, 2021

Study Completion Date

December 7, 2021

Conditions
MDDTreatment Resistant DepressionSmoking CessationSmoking
Interventions
DRUG

Dextromethorphan

Dextromethorphan will be administered and its tolerability evaluated.

Trial Locations (1)

21287

Johns Hopkins Department of Psychiatry, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER

NCT04226352 - Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder | Biotech Hunter | Biotech Hunter